Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to study the efficacy of three candidate molecules (Xenbilox,
Tahor and Resveratrol) in order to decrease the production of oxysterols by reducing the
synthesis of cholesterol and/or regulate the production of bile acids and/or enabling
neuroprotective action within the motor neuron.